Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
Giorgia Sulis, Madhukar Pai, Sumanth Gandra
Author Information
- Giorgia Sulis: Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada. ORCID
- Madhukar Pai: Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Canada.
- Sumanth Gandra: Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis Missouri, USA.
No abstract text available.
- Pathog Glob Health. 2022 Oct;116(7):421-427
[PMID: 34783630]
- Antibiotics (Basel). 2021 Jun 18;10(6):
[PMID: 34207020]
- Antimicrob Steward Healthc Epidemiol. 2022 Feb 18;2(1):e27
[PMID: 36310817]
- Res Rep Trop Med. 2020 Sep 17;11:61-72
[PMID: 32982538]
- Trop Med Health. 2021 Jun 23;49(1):51
[PMID: 34162445]
- PLoS Med. 2021 Jul 1;18(7):e1003682
[PMID: 34197449]
- Infect Drug Resist. 2021 May 24;14:1893-1903
[PMID: 34079300]
- Front Pharmacol. 2022 Mar 21;13:844818
[PMID: 35387351]
- J Antimicrob Chemother. 2022 Apr 27;77(5):1491-1499
[PMID: 35178565]
- Antibiotics (Basel). 2021 Jun 09;10(6):
[PMID: 34207567]
Anti-Bacterial Agents
Anti-Infective Agents
COVID-19
Drug Resistance, Bacterial
Humans
Pandemics
World Health Organization
Anti-Bacterial Agents
Anti-Infective Agents
